A detailed history of Man Group PLC transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Man Group PLC holds 44,279 shares of SRTS stock, worth $301,097. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,279
Previous 35,847 23.52%
Holding current value
$301,097
Previous $191,000 34.03%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.93 - $7.05 $41,569 - $59,445
8,432 Added 23.52%
44,279 $256,000
Q2 2024

Aug 14, 2024

BUY
$3.14 - $6.42 $32,580 - $66,613
10,376 Added 40.74%
35,847 $191,000
Q1 2024

May 15, 2024

BUY
$2.49 - $4.91 $63,422 - $125,062
25,471 New
25,471 $96,000
Q3 2022

Nov 14, 2022

SELL
$7.64 - $14.97 $26,931 - $52,769
-3,525 Reduced 23.98%
11,175 $140,000
Q2 2022

Aug 15, 2022

BUY
$7.06 - $11.37 $103,782 - $167,139
14,700 New
14,700 $113,000

Others Institutions Holding SRTS

About Sensus Healthcare, Inc.


  • Ticker SRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,556,000
  • Market Cap $113M
  • Description
  • Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...
More about SRTS
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.